Omeros to Present at the 39th Annual J.P. Morgan Healthcare Conference
SEATTLE–(BUSINESS WIRE)–Omeros Corporation (Nasdaq: OMER) today announced that Gregory A. Demopulos, M.D., chairman and chief executive officer, will present at…
Pharmaceuticals, Biotechnology and Life Sciences
SEATTLE–(BUSINESS WIRE)–Omeros Corporation (Nasdaq: OMER) today announced that Gregory A. Demopulos, M.D., chairman and chief executive officer, will present at…
SEATTLE–(BUSINESS WIRE)–Omeros Corporation (Nasdaq: OMER) today announced that Gregory A. Demopulos, M.D., chairman and chief executive officer, will present at…
First quarter revenue of $10.7 million, reflecting 14% year-over-year growth Board of Directors announces quarterly dividend of $0.06 per share…
First quarter revenue of $10.7 million, reflecting 14% year-over-year growth Board of Directors announces quarterly dividend of $0.06 per share…
BOSTON–(BUSINESS WIRE)–Gamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to cures for blood cancers and serious hematologic…
BOSTON–(BUSINESS WIRE)–Gamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to cures for blood cancers and serious hematologic…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–$ALVR #celltherapy–AlloVir (Nasdaq: ALVR), a late clinical-stage cell therapy company, announced that it will present three oral presentations…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–$ALVR #celltherapy–AlloVir (Nasdaq: ALVR), a late clinical-stage cell therapy company, announced that it will present three oral presentations…
DUBLIN–(BUSINESS WIRE)–The “Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market 2020-2030 by Category, Service Type (CMO, CRO), Therapeutic Application,…
DUBLIN–(BUSINESS WIRE)–The “Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market 2020-2030 by Category, Service Type (CMO, CRO), Therapeutic Application,…